Nexalin Technology (NXL) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Outset Medical is the larger company by market cap ($75.8 million vs $3.1 million), about 24.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NXL | OM |
|---|---|---|
| Share price | $3.78 | $4.03 |
| Market cap | $3.14M | $75.75M |
| 1-day change | -8.03% | -1.47% |
| YTD return | — | +10.24% |
| 1-year return | — | -74.13% |
| 5-year return | — | -99.44% |
| EPS (TTM) | $-14.10 | $-4.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.70 | $15.94 |
| 52-week low | $3.50 | $2.84 |
| Distance from 52-week high | -92.54% | -74.72% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +296.83% | +90.32% |
| Average volume | 1.02M | 158.75K |
| Shares outstanding | 829.40K | 18.80M |
| Employees | 8 | 310 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Outset Medical is about 24.2 times larger than Nexalin Technology by market value ($75.75M vs $3.14M).
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees
NXL vs OM FAQ
Which is bigger, Nexalin Technology or Outset Medical?
Outset Medical (OM) is larger, with a market capitalization of $75.75M compared with $3.14M for Nexalin Technology (NXL).
Are Nexalin Technology and Outset Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.